Skip to main content
Warning Date
    2007-04-03

Withdraw pergolide from the market

2007-04-03

FDA notified healthcare professionals and patients that companies that manufacture and distribute pergolide have agreed to withdraw the drug from the market. Pergolide is a dopamine agonist (DA) used with levodopa and carbidopa to manage the signs and symptoms of Parkinson's disease. Results of two new studies showed that some patients with Parkinson's disease treated with pergolide had serious damage to their heart valves when compared to patients who did not receive the drug.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-04-11

Life-threatening Effects From Mixing Supplements, Herbs, Over-the-counter Medications And Prescription Drugs

2007-04-11

People are mixing supplements, herbs and over-the-counter medications and prescription drugs to cure themselves of ills, unaware that they could be making themselves sicker, says George Grossberg, M.D., director of the division of geriatric psychiatry at Saint Louis University.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-04-11

Inhaled Steroids Linked to Oropharyngeal Side Effects

2007-04-11

Inhaled corticosteroids used to treat asthma can cause a number of oropharyngeal adverse events, including candidiasis and dysphonia, US researchers report in the Annals of Allergy, Asthma, and Immunology for March.

The oropharyngeal side effects that arise with inhaled steroid use can affect adherence to these medications. However, these adverse events have received much less attention than the drugs' systemic side effects, note Dr. Gary S. Rachelefsky from UCLA School of Medicine, and colleagues

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-04-28

Increased Incidence of Fractures in Female Patients Who Received Long-Term Treatment with Avandia® (rosiglitazone maleate)

2007-04-28

In agreement with European Regulatory Authorities, GlaxoSmithKline (GSK) is informing you of recent safety data concerning rosiglitazone-containing products, i.e., Avandia® (rosiglitazone maleate) Tablets, Avandamet® (rosiglitazone maleate and metformin hydrochloride) Tablets, and Avaglim® (rosiglitazone maleate and glimepiride) Tablets. The information could be summarized as follows:

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-04-28

Aranesp ® is ineffective for non- chemotherapy induced anemia.

2007-04-28

Amgen notified the oncology medical community of the results of a large, multicenter, randomized, placebo-controlled study showing that Aranesp ® (Darbepoetin alfa) was ineffective in reducing red blood cell transfusions or fatigue in patients with cancer who have anemia that is not due to concurrent chemotherapy.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-01

Warning from the Medicines and Medical Devices Safety Authority on five Chinese medicine products

2007-05-01

Director-General of Health, Stephen McKernan, is warning people about the potential health dangers associated with 5 Chinese medicine products which have been found to contain undeclared prescription medicines for weight loss and erectile dysfunction.

This statement about the 5 products is being issued by the Director-General under Section 98 of the Medicines Act 1981, following investigations by the Ministry of Health's medicines safety arm, Medsafe.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-06

New information update for Pioglitazone

2007-05-06

Takeda and FDA notified healthcare professionals of recent safety data concerning pioglitazone-containing products. The results of an analysis of the manufacturer's clinical trial database of pioglitazone showed more reports of fractures in female patients taking pioglitazone than those taking a comparator (either placebo or active). The majority of fractures observed in female patients were in the distal upper limb (forearm, hand and wrist) or distal lower limb (foot, ankle, fibula and tibia).

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-07

Alert about Urat Madu

2007-05-07

The Singapore Health Sciences Authority found Urat Madu capsules to be adulterated with the prescription drug sildenafil. Sildenafil citrate is indicated for the treatment of erectile dysfunction, and has been associated with serious adverse reactions. Sildenafil is not intended for self-care, and should only be taken under the guidance of a health care professional.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-08

Warning Against Buying Accutane and Its Generic Versions Online

2007-05-08

The U.S. Food & Drug Administration (FDA) is launching a special Web page to warn consumers about the dangers of buying isotretinoin (Accutane) online. Isotretinoin is a drug approved for the treatment of severe recalcitrant nodular acne that does not respond to antibiotics. Improperly used, isotretinoin can cause severe side effects, including birth defects. Serious mental health problems have also been reported with isotretinoin use.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-23

FDA Panel Urges Stronger Warnings for Anemia Drugs

2007-05-23

A U.S. Food and Drug Administration advisory panel on Thursday called for new warnings and additional safety studies on anemia drugs commonly used to treat patients undergoing kidney dialysis or chemotherapy.

These medications have been the subject of controversy since some of their dangerous side effects -- including the risk of heart attacks and stroke -- came to light earlier this year. In March, the FDA issued stronger label warnings for the popular drugs.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Subscribe to Drugs